Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 1,105.00
+80.00 (7.80%)
Jul 16, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 70.62 billion as of July 15, 2026. Its market cap has increased by 793.21% in one year.
Market Cap
70.62B
Enterprise Value
68.77B
Revenue
25.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,105.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 70.62B, an increase of 1,171.10%. That is a compound annual growth rate of 194.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 70.62B | 252.03% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 167.31B |
| Lin BioScience | 50.69B |
| Oneness Biotech | 25.98B |
| CHO Pharma | 23.76B |
| Sunmax Biotechnology | 20.75B |
| Ever Supreme Bio Technology | 17.86B |
| TaiMed Biologics | 17.57B |
| Lumosa Therapeutics | 16.83B |